Liu, Chang
Liu, Hong
Dasgupta, Moumita
Hellman, Lance M.
Zhang, Xiaogang
Qu, Kai
Xue, Hui
Wang, Yun
Fan, Fenling
Chang, Qi
Yu, Duo
Ge, Linhu
Zhang, Yu
Cui, Ziyou
Zhang, Pengbo
Heller, Bradley
Zhang, Hongbing
Shi, Bingyin
Baker, Brian M.
Liu, Cheng
Article History
Received: 26 January 2022
Accepted: 1 July 2022
First Online: 15 July 2022
Competing interests
: HL, QC, DY, LG, YZ, ZC, PZ, BH, HZ and CL (Cheng Liu) are former or current employees of and have equity ownership and/or stock options in Eureka Therapeutics, Inc. All other authors declare no competing interests.